Strategic Growth Drivers Shaping the Pediatric Interventional Cardiology Market Outlook 2025- 2034:Surge In Congenital Heart Disease Fuels The Growth Of The Pediatric Interventional Cardiology Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Pediatric Interventional Cardiology Market Growth Evolved From 2024 To 2025, And What’s Ahead?
In recent times, the pediatric interventional cardiology market has witnessed robust growth. The market is expected to expand from $2.44 billion in 2024 to $2.6 billion in 2025, registering a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during the historic period include heightened awareness of mycotoxins, stricter regulatory norms, emphasis on animal health, global expansion of poultry production, competitive market conditions, and enhanced farm productivity.
In the next few years, the pediatric interventional cardiology market size is projected to witness substantial growth, propelling to $3.59 billion in 2029 with a compound annual growth rate (CAGR) of 8.4%. The advancement during the forecast period can be linked to the escalating poultry industry, effects of climate change, demand for natural products, dynamics of global trade, government strategies, and rising health awareness. Key trends for the forecast period encompass technology integration, feed security and quality, market unification, cooperative research endeavors, the digital shift in farming, and enhancements in feed technology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10384&type=smp
Which Factors and External Forces Are Driving Demand in the Pediatric Interventional Cardiology Market?
The pediatric interventional cardiology market is anticipated to grow due to the rising incidence of congenital heart disease. Congenital heart disease refers to any issue with the heart’s structure that has been present since birth. The treatment of this condition using pediatric interventional cardiology procedures offers several benefits over traditional open-heart surgery, such as faster recovery, lower infection risk, and minimal scarring. For example, data from the American Heart Association in 2022, a non-profit organization specializing in cardiac medical research based in the U.S., revealed that congenital heart defects affect approximately 40,000 infants, with a birth prevalence estimated at 12.3 per 1000. Additionally, a 2022 article published by The Lancet, a renowned UK-based medical journal, reported that congenital heart disease is the most widespread birth defect, impacting nearly 9 in every 1000 live births. As such, the escalating prevalence of congenital heart disease is anticipated to stimulate the pediatric interventional cardiology market’s growth.
Which Segments in the Pediatric Interventional Cardiology Offer the Most Growth?
The pediatric interventional cardiologymarket covered in this report is segmented –
1) By Device Type: Closure Devices, Trans catheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Other Device Types
2) By Procedure: Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Other Procedures
3) By End-Use: Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions
Subsegments:
1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR) Devices, Transcatheter Mitral Valve Repair Devices, Transcatheter Pulmonary Valve Replacement Devices
3) By Atherectomy Devices: Directional Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices
4) By Catheters: Diagnostic Catheters, Therapeutic Catheters, Guiding Catheters
5) By Balloons: Balloon Angioplasty Balloons, Intra-Aortic Balloons, High-Pressure Balloons
6) By Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Stents
7) By Other Device Types: Vascular Closure Devices, Hemodynamic Monitoring Devices, Electrophysiology Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=10384&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Pediatric Interventional Cardiology Market?# Market?
North America was the largest region in the pediatric interventional cardiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Cutting-Edge Market Trends Are Expected to Drive thePediatric Interventional Cardiology Market’s Growth?
The trend of product innovation is significant within the pediatric interventional cardiology industry. Major players in the field are launching innovative solutions to bolster their market standing. For example, Medtronic plc., a medical devices firm based in the U.S, deployed a new trans catheter pulmonary valve named the Harmony Transcatheter Pulmonary Valve System in February 2023. The Harmony TPV system offers a minimally invasive alternative to open-heart surgery, making it possible to be implanted through a small cut in the neck or leg. It is designed for patients who have previously had surgery for congenital heart disease and have a dysfunctional RVOT (right ventricular outflow tract) due to a previously implanted conduit or bio prosthetic pulmonary valve. Additionally, it caters to patients with native or patched RVOT who need a pulmonary valve replacement.
View the full report here:
What Are the Key Elements That Define the Pediatric Interventional Cardiology Market?
Pediatric interventional cardiology refers to procedures that use cardiac catheterization in children to diagnose and treat congenital heart defects. Pediatric interventional cardiology is used for treating heart conditions with minimally invasive surgical procedures.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10384
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
